Washington SB5921 establishes a medical use of psilocybin program under the supervision of the Department of Health.
Washington SB5921 creates a medical use of psilocybin program within the Department of Health. The program aims to provide safe access to psilocybin for medically significant relief of diagnosed conditions. It includes provisions for licensing producers and clinicians, establishing treatment protocols, and ensuring secure handling and storage of psilocybin products. The bill also outlines protections for clinicians and patients, ensuring they are not subject to arrest or prosecution for participating in the program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.